ANALYSIS OF THE RESULTS OF THE IMMUNOENZYME STUDY FOR COVID-19 (LITERATURE REVIEW)
Аннотация
The literature review considers methods for detecting coronavirus infection, the sensitivity and specificity of laboratory tests, the determination of antigens or antibodies, their advantages and disadvantages. Laboratory tests reflect the state of immunity, the development of the disease, damage to organs and systems, and the quality of treatment. The correct appointment and interpretation of the test result is important for obtaining additional information in the diagnosis, for choosing the right treatment for the disease and predicting its development. In general, laboratory diagnostic methods aimed at identifying nucleic acids, antigens or antibodies are of great importance.
Библиографические ссылки
Бабаджанов А.С., Курбонова З.Ч. и др. Патология коагуляционного гемостаза при циррозе печени и COVID-19// Вестник Ташкентской медицинской академии. – 2021. - №1. – С. 15-16.
Бабаджанов А.С. Бабаджанова Ш.А., Курбанова З.Ч., Миразимов Д.Б. Анализ частоты и структуры тромбоэмболических осложнений и состояния гемокоагуляции у больных COVID-19 // Инфекция, иммунитет и фармакология. – 2021. - №3. – С. 42-50.
Бабаджанова Ш.А., Курбонова З.Ч., Муминов О.А. Частота тромбоэмболических осложнений у больных с коронавирусной инфекцией //Назарий ва клиник тиббиёт. – 2021. - №5. – С. 146-149.
Костюк С.А., Симирский В.В. // Цитокиновый шторм при COVID-19 //Клиническая практика и здоровье. – 2021. – №1. –Р. 41.
Курбонова З.Ч., Бабаджанова Ш.А. Коронавирус инфекциясида гемостаз патологиясини лаборатор ташхислаш ва даволаш: услубий тавсиянома. Тошкент, 2022. - Б. 14-16.
Курбонова З. Ч, Бабаджанова Ш.А. Коронавирус инфекциясида тромбоцитар гемостаз бузилишининг лаборатор диагностикаси // Zamonaviy klinik laborator tashxisi dolzarb muammolari. – 2022. – B.127-129.
Курбонова З. Ч, Бабаджанова Ш.А. COVID – 19 да антиагрегант терапия самарадорлигинибаҳолаш // Zamonaviy klinik laborator tashxisi dolzarb muammolari. – 2022. – B.129-131.
Курбонова З.Ч, Бабаджанова Ш.А., Сердал Коркмаз, Хўшбоқова Г.Ў. COVID-19 бўлгaн беморлaрдa қон кўрсaткичлaри// O'zbekistonda fanlararo innovatsiyalar va ilmiy tadqiqotlar jurnali. – 2023. - №17. – B. 426-432.
Курбонова З.Ч., Бабаджанова Ш.А. Коронавирус инфекциясида коагуляцион гемостаз бузилишининг лаборатор диагностикаси // Zamonaviy tibbiyotda klinik labarator innovatsiyalarning ahamiyati. – 2022. - №1. – Б. 125-127.
Курбонова З.Ч., Бабаджанова Ш.А., Муминов О.А. Лабораторный мониторинг патологии коагуляционного гемостаза у больных COVID-19// Назарий ва клиник тиббиёт. – 2021. №5. – С. 149-151.
Курбонова З.Ч., Бабаджанова Ш.А. и др. Характеристика функции тромбоцитов при COVID-19 // Тошкент тиббиёт академияси ахборотномаси. – 2021. -№1. – Б. 34-36.
Курбонова З.Ч., Муминов О.А. СOVID-19 этиологияси ва патогенези тўғрисидаги замонавий талқин // Назарий ва клиник тиббиёт. – 2021. - №5. – Б. 84-86.
Курбонова З.Ч., Муминов О.А. Коронавирус инфекцияси клиник хусусиятлари // Назарий ва клиник тиббиёт. – 2022. - №5. – С. 87-89.
Курбонова З.Ч.Коронавирус инфекциясида томир-тромбоцитар гемостаз патологияси // Педиатрия. 2023. №4. С. 121-125.
Курбонова З.Ч. Коронавирус инфекциясида томир-тромбоцитар гемостаз патологияси // Педиатрия. – 2023. - №4. – Б. 121-125.
Курбонова З.Ч., Бабаджанова Ш.А. Коронавирус инфекцияси клиник хусусиятларини баҳолаш //Ўзбекистон врачлар ассоциациясининг бюллетени. – 2022. - №4. – Б. 65-69
Курбонова З.Ч. Оценка коагуляционного гемостаза при COVID-19// Вестник Ташкентской медицинской академии. – 2021. - №1. – С. 53.
Муминов О.А., Курбонова З.Ч. COVID-19 патогенетик аспекти // Zamonaviy klinik laborator tashxisi dolzarb muammolari. – 2022. – B.139-141.
Муминов О.А., Курбонова З.Ч. COVID-19 клиник хусусиятлари // Zamonaviy klinik laborator tashxisi dolzarb muammolari. – 2022. – B.137-139.
Alimova U.O., Akbarova O’., Kurbonova Z.Ch. Shoshilich holatlarda COVID-19 bilan kasallangan bemorlarda laborator ko’rsatkichlar dinamikasining retrospektiv tahlili // Digitalization is the future of medicine. – 2021. – B. 383-385.
Aladag N. et al. Containment measures established during the COVID-19 outbreak and its impact on lipid profile and neutrophil to lymphocyte ratio. //Eur. Rev. Med. Pharm. Sci. – 2020. – №24. –Р. 12510–12515.
AnisenkovaA.Yu., Apalko S.V. Major predictive risk factors for а cytokine storm in COVID-19. //Клиническаяпрактика. -2021. - №12. –P. 5–15.
Babadjanova Sh.A., Mirazimov D.B., Kurbonova Z.Ch., Saidov A.B. et al. Analysis of hemostasis indicators in patients with coronavirus infection // Annals of Romanian Society of cell biology. – 2021. - Vol.25 (4). – P. 13111-13119.
Babadjanova Sh.A., Kurbоnova Z.Ch., Khushbokova G.U. Retrospective analysis of blood indicators in patients with coronavirus infection// Medicine and health sciences. – 2021. Vol.3. – P. 22-23.
Babadzhanova Sh.A. Kurbonova Z.Ch. Pathology Of Vascular-Platelet And Coagulation Hemostasis In Coronavirus Infection (Literature Review)// Eurasian Medical Research Periodical. – 2022. - №14. – С. 149-156.
Chauhan D. S. et al. Comprehensive review on current interventions, diagnostics, and nanotechnology perspectives against SARS-CoV-2. //Bioconjugate Chem. –2021. - №31. –P. 20-45.
Chenxi Lia, ChengxueZhaoa, et al. Laboratory diagnosis of coronavirus disease-2019 (COVID-19).//Clin Chim Acta. – 2020.- №510. –P.35-46.
Dinnes J. et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. //Cochrane Database Syst. Rev. – 2021. - №3. –P. 4-10.
Eshghifar N., Busheri A., et al. Evaluation of analytical performance of seven rapid antigen detection kits for detection of SARS-CoV-2 virus. //Int. J. Gen. Med. - 2021. - №14. -P. 435–440.
Fan Z. et al. Clinical features of COVID-19-related liver functional abnormality. //Clin. Gastroenterol. Hepatol. - 2020. - №18. -P. 1561–1566.
Fan J. et al. The lung tissue microbiota features of 20 deceased patients with COVID-19. //J. Infect. - 2020. - №81. -P. 64–67.
Harikrishnan Jayamohan et al. SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations. //Analytical and Bioanalytical Chemistry. - 2021. - №413. –P. 49-71.
He Y., Wang J. et al. Main clinical features of COVID-19 and potential prognostic and therapeutic value of the microbiota in SARS-CoV-2 infections. //Front. Microbiol. - 2020. - №1. -P. 1302.
Igli Z. et al. Clinical evaluation of Roche SD biosensor rapid antigen test forSARS-CoV-2 in municipal health service testing site the Netherlands.//Emerg.Infect. Dis. - 2021. - №27. –P. 1323–1329.
Kandeel M., Ibrahim A. et al. From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and nonstructural genes. //J. Med. Virol. – 2020. – №92. –Р. 660–666.
Kohmer N., Westhaus S. et al. Clinical performance of SARS-CoV-2 IgG antibody tests and potential protective immunity.//J Med Virol. – 2020. – №92. –Р. 2243-2247.
Kurbonova Z.Ch. Babadjanova Sh.A. Charakteristics of Coagulation Hemostasis in Corona Virus Infection// Jundishapur journal of Microbiology. –2022. -No2 (15). –С. 453-460.
Kurbonova Z.Ch., Babadjanova Sh.A. Violations of coagulative hemostasis in patients with liver cirrhosis of the viral etiology //European science review. –2018. –No. 7-8.–С. 128-130.
Kurbonova Z.Ch., Xo’shboqova G.O’. Alimova U.O. Covid-19 bo'lgan bemorlarda qon korsatkichlari // Toshkent tibbiyot akademiyasi axborotnomasi. – 2021. - №1. – B. 31-34.
Kurbonova Z.Ch., Babadzhanova, Sh.A., Serdal, Korkmaz, Muminov, O.A., Khushbokova, G.U. Blood measures in patients with COVID-19 // Spectrum Journal of Innovation, Reforms and Development. – 2023. – Vol. 13. – P. 118-124.
Kurbonova Z.Ch. et al. SARSCov-2 bilan og’rigan bemorlarda koagulyatsion gemostazni shikastlanishini laboratoriyaviy ko’rsatgichlarini baxolash// Тошкент тиббиёт академияси ахборотномаси. - №1. – B. 84-86.
Nalleballe K. et al. Spectrum of neuropsychiatric manifestations in COVID-19.//Brain Behav. Immunity. – 2020. – №88. –Р. 71–74.
Meghana Rastogi, Neha Pandey et al.SARS coronavirus-2 from genome to infectome. //Respir Res. – 2020. – №21. –Р. 318.
Muench P. et al. Development and validation of the elecsys anti-SARS-CoV-2 immunoassay as a highly specific tool for determining past exposure to SARSCoV-2.//Clin. Microbiol. – 2020. – №58. –Р. 11-28.
Padoan A., Sciacovelli L. et al. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: a longitudinal study.//Clin. Chim. Acta– 2020. - №507. - P- 164–166.
Porte L. et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples. //Int. J. Infect. Dis. – 2020. – №99. –Р. 328–333.
Rachel West, Amanda Kobokovich Understanding the Accuracy of Diagnostic and Serology Tests: Sensitivity and Specificity.//The Johns Hopkins University. All rights reserved.– 2020. –Р. 1-4.
Saidov A.B. Kurbonova Z.Ch. et al. COVID-19 da koagulyasion gemostazni baxolash //Biofizika va biokimyo muammolari. - 2021. – B. 24-25.
Saidov A.B., Kurbonova Z.Ch. et al. COVID-19 da tromboz kelib chiqishi omillari // Инновационное развитие науки и образования, Казахстан, Павлодар. – 2021. - №1. – С. 11-12.
Saidov A.B., Kurbonova Z.Ch. et al. COVID-19 bilan kasallanganlarda tromboz kelib chiqishi ko’rsatkichlarini baxolash// Polish science journal, Poland, Warsaw. – 2021. – Vol.4. – P. 137-139.
Schwab P. et al. Real-time prediction of COVID-19 related mortality using electronic health records. //Nat. Commun. – 2021. – №12. –Р. 1058.
Tang H. et al. Serologic detection of SARS-CoV-2 infections in hemodialysis centers: a multicenter retrospective study in Wuhan, China. //Am. J. Kidney Dis. – 2020. – №76. –Р490–499.
Thommes L. et al. Comparative evaluation of four SARS-CoV-2 antigen tests in hospitalized patients.//Int. J. Infect. Dis. – 2021. – №105. –Р. 144–146.
Xo‘shboqova G.O‘.,Kurbonova Z.Ch. et al. COVID-19da yalig‘lanish markerlari o‘zgarishi// Biofizika va biokimyo muammolari. - 2021. – B. 26.
World Health Organization. Laboratory testing for coronavirus disease (COVID-19) in suspected human cases: interim guidance.//World Health Organization. – 2020. – №5. –Р. 1-7.
Zirui Meng1, Shuo Guo1 et al Applications of laboratory findings in the prevention, diagnosis, treatment, and monitoring of COVID-19. //Transduction and Targeted Therapy. – 2021. – №6. –Р. 316.
